SCIESCOPUSQ2
EXPERT OPINION ON EMERGING DRUGS
TAYLOR & FRANCIS LTD, United Kingdom
EXPERT OPINION ON EMERGING DRUGS is an academic journal published by TAYLOR & FRANCIS LTD (United Kingdom). Identifiers: ISSN 1472-8214, eISSN 1744-7623. Indexed in SCIE, SCOPUS. Metrics: JIF 2.7, CiteScore 4.7, SJR 1.034, SNIP 0.54. Subject areas: PHARMACOLOGY & PHARMACY. tlooto lists 985 papers from this journal.
CiteScore
4.70
Scopus citation metric
SJR
1.034
SCImago rank
SNIP
0.54
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1472-8214
- eISSN
- 1744-7623
- Abbreviation
- EXPERT OPIN EMERG DR
- Publisher
- TAYLOR & FRANCIS LTD
- Country
- United Kingdom
Web of Science categories
SCIEPHARMACOLOGY & PHARMACY
Scopus ASJC categories
2736 Pharmacology (medical)3004 Pharmacology
Keywords
Pharmacology & Pharmacy
Papers in this journal
Recent papers
- Emerging treatment options for chronic obstructive pulmonary disease: a look into 2026 and beyond.
2026
- Potassium channel agonists emerging as treatment options for focal epilepsy: are we breaking new ground?
2026
- Emerging biological drugs for the treatment of patients with metastatic HER2+ gastroesophageal adenocarcinomas
2026
- Evaluating emerging amyloid-β centric drugs for the treatment of Alzheimer's disease.
2026
- Obefazimod (ABX464) for Moderate-to-Severe Crohn's disease: clinical development of a novel oral therapeutic approach.
2026
Most cited papers
- Emerging PEGylated drugs
2009 · 246 citations
- Emerging treatments for traumatic brain injury
2009 · 238 citations
- What is the future of PEGylated therapies?
2015 · 220 citations
- Transgenic plants in the biopharmaceutical market
2005 · 199 citations
- Emerging treatments for noise-induced hearing loss
2011 · 184 citations